Publication | Closed Access
Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric Cancer
263
Citations
25
References
1999
Year
This combination chemotherapy regimen is active and well tolerated. It may be an appropriate regimen for future phase III trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1